Loading...

Eledon Pharmaceuticals, Inc.

ELDNNASDAQ
Healthcare
Biotechnology
$3.30
$0.10(3.12%)
U.S. Market opens in 14h 54m

Eledon Pharmaceuticals, Inc. (ELDN) Stock Forecast & Price Predictions

Get the latest Eledon Pharmaceuticals, Inc. (ELDN) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.

Model Information

The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Monthly Forecast

Predicted Price$3.25
Change↓ $-0.05 (-1.52%)

Quarterly Forecast

Predicted Price$0.75
Change↓ $-2.55 (-77.27%)

Yearly Forecast

Predicted Price$1.06
Change↓ $-2.24 (-67.89%)

3 Years Forecast

Predicted Price$0.00
Change↓ $-3.30 (-100.00%)

5 Years Forecast

Predicted Price$0.00
Change↓ $-3.30 (-100.00%)

7 Years Forecast

Predicted Price$0.00
Change↓ $-3.30 (-100.00%)

Eledon Pharmaceuticals, Inc. Stock Forecast Summary

Eledon Pharmaceuticals, Inc. (ELDN) stock is currently priced at $3.30. Based on Meyka AI predictions, the short-term outlook is bearish, with momentum pointing higher. The 1-month projection suggests a move toward $3.25.

In the long term, ELDN shows a bearish trend. The 2027 forecast points to $1.06 (-67.89% change), while the 2031 forecast suggests $0.00 (-100.00% change). Looking 7 years ahead, projections estimate the stock could trade near $0.00, a -100.00% change from today’s price.

Overall Sentiment

Bearish

Short-Term Outlook

Bearish

Long-Term Outlook

Bearish

This mix indicates that Eledon Pharmaceuticals, Inc. stock is expected to face downside risk over the coming years.

Investment Calculator

Estimate your potential returns on ELDN using our advanced Investment Calculator with AI-driven price forecasts. Enter your investment amount and select a target date to view expected results, including estimated profit, loss, and ROI performance.

Based on your investment of $1,000.00 in Eledon Pharmaceuticals, Inc. and holding until April 15th, 2027, you could face a potential $678.92 loss, reflecting a -67.9% ROI over the next 365 days. These projections help you better understand short-term market movements.

$

$Shares Bought

303.0303

@ $3.30/share

~Forecast Price

$1.06

1-year AI forecast

$Est. Portfolio Value

$321.08

$678.92 loss

%ROI

-67.9%

return on investment

Eledon Pharmaceuticals, Inc. yearly Price Forecast Chart

Explore the yearly forecast chart for ELDN, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Eledon Pharmaceuticals, Inc. over different timeframes.

No forecast data available

No prediction data found for this time period.

empty-state-iconForecasting data is not available for ELDNForecasting details for ELDN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Eledon Pharmaceuticals, Inc. Stock Forecast 2026

The forecast for Eledon Pharmaceuticals, Inc. (ELDN) in 2026 suggests a price of $1.06, representing a -67.89% move from today’s price.

Average Target: $1.06

Market Outlook: bearish based on current trend indicators.

Key Drivers in 2026:
  • Earnings growth projections.
  • Competitive performance in the Healthcare.
  • Macroeconomic factors such as interest rates and inflation.

Frequently Asked Questions